Clinical Characteristics and Risk Factors for Critically Ill Patients with Carbapenem-Resistant Klebsiella pneumonia e (CrKP): A Cohort Study from Developing Country.

Ying-Yi LuanYan-Hong ChenXue LiZhi-Peng ZhouJia-Jia HuangZhen-Jia YangJing-Jing ZhangMing Wu

Published in: Infection and drug resistance (2021)

Therapeutic strategy based on improving lactic acid and APACHE II would contribute to the outcome in patients with CrKP infection. Tigecycline combined with fosfomycin could reduce the 28-day mortality in patients with CrKP infection in developing country.

Keyphrases

lactic acid
klebsiella pneumoniae
cardiovascular disease
escherichia coli
intensive care unit
cystic fibrosis
coronary artery disease
pseudomonas aeruginosa
gram negative
mechanical ventilation